Multiple Sclerosis, Relapsing-Remitting Clinical Trials in Cincinnati, Ohio

Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis